Consequently, elevated MMP-2 in myopia results from: Disrupted dopamine signaling (light exposure to D2R activation and MMP-2); Therapeutic MMP-2 inhibition (e.g., TIMP-2 gene therapy, doxycycline) synergizes with cAMP-elevating agents to preserve scleral integrity (156). Here, TIMP2 is linked to myopia.